L’évolution de la part de marché de

L’évolution de la part de marché de l’OCREVUS va évoluer dans le temps car c’est le seul indiqué dans la Sclérose en plaques primaire progressive(qui représente environ 10% des formes de SEP en Algérie).

Results (English) 1:

The evolution from OCREVUS market will evolve over time because it is the only indicated in primary progressive Multiple sclerosis (representing approximately 10% of the forms of MS in Algeria).

Results (English) 2:

The evolution of the market share of OCREVUS will change over time because it is the only one indicated in progressive primary multiple sclerosis (which accounts for about 10% of MS forms in Algeria).

Results (English) 3:

"Ocreview" market share will change over time as it is the only one shown in progressive primary multiple sclerosis (, about 10% of Algerian SEP forms).